Avodart (Dutasteride) Dosing in Geriatric Patients (65+)
Evidence-based guide to dutasteride 0.5 mg dosing in adults aged 65 and older, covering pharmacokinetics, BPH efficacy, renal considerations, drug interactions, and deprescribing.
Dutasteride
48 source-based articles maintained by the HealthRX.com Editorial Team.
48articles
6topic areas covered
May 25, 2026latest review
Dutasteride library
Showing 48 of 48 clinical reviews.
Avodart (Dutasteride) Geriatric Monitoring: What Every Clinician Needs to Know for Patients 65+
A clinical guide to dutasteride (Avodart) monitoring in adults 65 and older, covering falls risk, renal considerations, drug interactions, PSA interpretation, and deprescribing thresholds.
Avodart (Dutasteride) Monitoring for Older Adults Ages 50 to 64
A guide to dutasteride (Avodart) monitoring protocols for men and women aged 50 to 64, covering PSA interpretation, cardiovascular checks, hormone interactions, and safety labs at each follow-up visit.
Avodart (Dutasteride) Off-Label Uses With Evidence Levels
A guide to dutasteride's off-label applications beyond BPH, including androgenetic alopecia, hirsutism, and prostate cancer chemoprevention, with evidence grades and cited clinical trials.
Avodart (Dutasteride) Regulatory Status: US, EU, Canada, and UK Approval History
A clinician-level review of dutasteride (Avodart) regulatory approvals across the US, EU, Canada, and UK, including BPH indications, off-label hair loss use, and key differences between jurisdictions.
Avodart (Dutasteride) Safety for Adults Ages 30 to 49
A guide to dutasteride (Avodart) safety in adults aged 30, 49, covering sexual side effects, cardiovascular signals, cancer risk, drug interactions, and how to weigh risks against benefits for BPH and hair loss.
Avodart (Dutasteride) Safety for Young Adults Ages 18 to 29: What the Evidence Actually Shows
A guide to dutasteride safety in young adults ages 18, 29, covering sexual side effects, fertility, mental health signals, contraindications, and monitoring protocols with primary-source citations.
Avodart Adult (30-49) Dosing: Dutasteride Dose Guide for Men in Their 30s and 40s
Complete dutasteride dosing guide for adults aged 30-49, covering FDA-approved BPH doses, off-label hair loss use, clinical trial data, and practical management tips for men in their peak working years.
Avodart Autoimmune Disease Considerations: What Clinicians and Patients Need to Know
A clinician-level review of dutasteride (Avodart) and autoimmune disease: drug-induced lupus risk, thyroid interactions, immunomodulatory mechanisms, dosing cautions, and how to monitor patients with pre-existing autoimmune conditions.
Avodart Cognitive Function Impact: What the Evidence Actually Shows
An evidence-based look at dutasteride (Avodart) and cognitive function, covering neurosteroid pathways, clinical trial data, risk stratification, and what patients should discuss with their prescribers.
Avodart Cost vs. Alternatives: Dutasteride Pricing and 5-ARI Comparison
Compare the cost of dutasteride (Avodart) against finasteride, tamsulosin, and combination therapies for BPH and hair loss. Includes generic pricing, insurance coverage, and clinical value analysis.
Avodart Dosing in Renal Impairment: What Clinicians and Patients Need to Know
A clinician-level review of dutasteride (Avodart) dosing in renal impairment, covering pharmacokinetics, mechanism of action, trial data, and practical prescribing guidance.
Avodart Geriatric (65+) Safety: What Older Men Need to Know About Dutasteride
A guide to dutasteride (Avodart) safety in men aged 65 and older, covering renal function, falls risk, drug interactions, cardiovascular signals, and deprescribing criteria.
Avodart Hair and Skin Changes: What Dutasteride Does to Your Scalp, Follicles, and Skin
What oral dutasteride evidence really shows for male pattern hair loss, what it does not establish about dry skin or sebum, and how its long half-life, sexual effects, fertility, pregnancy-exposure, and PSA warnings change the decision.
Avodart History and Development: How Dutasteride Went from Prostate Drug to Hair Loss Contender
A clinical history of dutasteride (Avodart), from GSK's dual 5-alpha reductase inhibitor development through FDA approval for BPH and its off-label rise in androgenetic alopecia treatment.
Avodart Info: Dutasteride Safety for Adults 50 to 64
Avodart (dutasteride) info for ages 50-64: half-life, DHT suppression, REDUCE trial prostate cancer data, sexual side effects, and drug interaction risks.
Avodart Liver Function Impact: What Dutasteride Does to Your Liver
A clinical deep-dive into how dutasteride (Avodart) affects liver function, what the trial data shows, when to monitor LFTs, and which patients face the highest risk.
Avodart Manufacturing, Supply & Shortage History
A clinical review of dutasteride (Avodart) manufacturing, GSK production history, soft gelatin capsule supply challenges, generic market entry, and documented shortage events.
Avodart Mental Health and Mood Impact: What the Evidence Actually Shows
A deep dive into dutasteride (Avodart) and its effects on mood, depression, anxiety, libido, and cognitive function, with primary-literature citations and clinical guidance.
Avodart Muscle Preservation Strategies: What the Evidence Actually Shows
A clinician-level review of dutasteride (Avodart) and muscle preservation strategies, covering DHT suppression, resistance training protocols, protein targets, and monitoring guidance backed by primary-source evidence.
Avodart Patent History and Generic Dutasteride Timeline
A detailed look at dutasteride (Avodart) patent expiry dates, Paragraph IV challenges, generic approvals, and what the post-exclusivity market means for BPH and hair loss patients.
Avodart Pharmacokinetics (ADME): How Dutasteride Is Absorbed, Distributed, Metabolized, and Eliminated
A clinical deep-dive into dutasteride (Avodart) pharmacokinetics covering absorption, distribution, metabolism, elimination, its 5-week half-life, CYP3A4 metabolism, and DHT suppression kinetics.
Avodart Rebound Effects When Stopping: What the Evidence Actually Shows
An evidence-based breakdown of what happens when you stop dutasteride (Avodart): DHT rebound, hair loss reversal, BPH symptom return, and how to taper safely.
Avodart Sleep Architecture Impact: What Dutasteride Does to Your Sleep
A clinician-level review of how dutasteride (Avodart) affects sleep architecture, including neurosteroid suppression, REM disruption, and clinical management strategies backed by primary literature.
Avodart Storage, Stability & Shelf Life: What Patients and Clinicians Need to Know
Complete guide to dutasteride (Avodart) storage conditions, shelf-life data, chemical stability, and what happens when capsules are exposed to heat, moisture, or light, with PubMed and FDA citations.
Avodart What to Expect: Week-by-Week First Month on Dutasteride
A week-by-week guide to the first 30 days on dutasteride (Avodart) for BPH and hair loss. Covers DHT suppression timelines, shedding phases, side effects, and what your lab work should show.
Avodart Young Adult (18 to 29) Monitoring: What to Track, How Often, and Why
A guide to dutasteride (Avodart) monitoring for men aged 18 to 29, covering labs, fertility, sexual side effects, PSA interpretation, and when to stop treatment.
Does Cigna Cover Avodart (Dutasteride)? Coverage, PA, and Appeal Guide
Find out whether Cigna covers Avodart (dutasteride) for BPH and hair loss, what prior-authorization criteria apply, how step therapy works, and how to appeal a denial.
Does State Medicaid Cover Avodart (Dutasteride)? Coverage, Prior Authorization, and Appeals
State Medicaid coverage for Avodart (dutasteride) varies widely. Learn formulary status, prior authorization requirements, step therapy rules, and how to appeal a denial.
Does TRICARE Cover Avodart (Dutasteride)? Formulary Tier, Prior Authorization, and Appeal Steps
TRICARE covers generic dutasteride on its formulary for BPH, but brand-name Avodart may require prior authorization. Learn about formulary tiers, step therapy, appeal processes, and cost-saving strategies for military beneficiaries.
Does UnitedHealthcare Cover Avodart (Dutasteride)?
UnitedHealthcare typically covers Avodart (dutasteride) on Tier 3 with prior authorization for BPH. Learn formulary placement, PA criteria, step therapy rules, appeal steps, and cost-saving alternatives.
Dutasteride (Avodart) Dosing in Hepatic Impairment: What Clinicians Need to Know
Evidence-based guide to dutasteride pharmacokinetics, CYP3A4 metabolism, and dose considerations in patients with liver disease. Includes FDA label gaps, clinical reasoning, and monitoring strategies.
Dutasteride (Avodart) Food & Supplement Interactions: What to Avoid and Why
Evidence-based guide to dutasteride food and supplement interactions, including saw palmetto, St. John's wort, grapefruit, and fat-soluble vitamin concerns.
Dutasteride (Avodart) Future Formulations and Pipeline: What Is Coming Next?
A clinician-level review of dutasteride pipeline developments, novel delivery systems, combination therapies, and emerging indications beyond BPH and androgenetic alopecia.
Dutasteride (Avodart) in Special Populations: Transplant, HIV, Hepatic Impairment, and Beyond
Evidence-based guide to prescribing dutasteride in transplant recipients, people living with HIV, patients with hepatic or renal impairment, and other special populations. Includes drug interactions, dose adjustments, and monitoring protocols.
Dutasteride (Avodart) Missed-Dose Protocol: What to Do and Why It Matters Less Than You Think
Evidence-based guide to handling a missed dose of dutasteride (Avodart). Covers pharmacokinetics, the 5-week half-life advantage, clinical impact, and step-by-step instructions.
Dutasteride (Avodart) Monitoring for Adults Ages 30 to 49
Evidence-based monitoring guide for dutasteride (Avodart) in adults aged 30-49, covering PSA adjustments, liver function, hormonal panels, and safety labs for BPH and hair loss.
Dutasteride (Avodart) Monitoring Schedule: Labs, Exams, and Follow-Up Timeline
Evidence-based monitoring schedule for dutasteride (Avodart), including baseline labs, PSA adjustments, liver function testing, and follow-up exam intervals for BPH and hair loss.
Dutasteride (Avodart) Overdose: What to Do After an Accidental Excess Dose
Evidence-based guide to managing dutasteride (Avodart) overdose or accidental double dosing, including pharmacokinetic data, clinical safety margins, and when to seek emergency care.
Dutasteride (Avodart) Pregnancy and Lactation Safety: What Clinicians and Patients Need to Know
Dutasteride (Avodart) is FDA Pregnancy Category X. This article covers teratogenic risk, blood donation restrictions, partner exposure precautions, lactation data, and clinical guidance for 5-alpha reductase inhibitor use near conception.
Dutasteride (Avodart) Safety Signals and FDA Actions: What the Evidence Shows
A clinician-grade review of dutasteride (Avodart) safety signals, FDA label changes, the REDUCE trial prostate cancer finding, sexual adverse effects, and mental health concerns, with PubMed-cited evidence.
Dutasteride (Avodart): Mechanism, Dosing, and Why There Is No Self-Injection Form
A guide to how dutasteride works, its oral dosing for BPH and hair loss, why no injectable form exists, and what the clinical evidence says about efficacy and safety.
Dutasteride Half-Life 5 Weeks: FDA Dosing Info
Dutasteride's half-life is 5 weeks at steady state, the longest of any 5-alpha reductase inhibitor. FDA dose is 0.5 mg daily, no age adjustment needed.
Dutasteride Interactions: CYP3A4 Drugs, Warfarin, Digoxin
Dutasteride interacts most with strong CYP3A4 inhibitors like ketoconazole, raising its levels 2.5-fold. No clinically significant effect on warfarin or digoxin.
Dutasteride Mechanism of Action: The Complete Pathway from Enzyme Inhibition to Clinical Effect
A physician-level explanation of how dutasteride (Avodart) works, covering dual 5-alpha reductase inhibition, DHT suppression kinetics, tissue-level effects in prostate and scalp, and how its pharmacology compares to finasteride.
Dutasteride Pharmacogenomics: How Genetic Variability Shapes Avodart Response
A clinical deep-dive into how CYP3A4, SRD5A1, SRD5A2, and androgen receptor gene polymorphisms influence dutasteride metabolism, efficacy, and side-effect risk.
Stopping Dutasteride: Follow-Up After the Last Dose
Stopping dutasteride: what to record about urinary symptoms, PSA, hair changes and sexual effects, plus the six-month blood donation wait.
Switching To or From Dutasteride (Avodart): A Clinical Protocol Guide
Everything clinicians and patients need to know about switching between dutasteride, finasteride, and other 5-alpha-reductase inhibitors, with trial evidence, dosing protocols, and pharmacokinetic rationale.